Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New MDC Research Report Published

17.02.2012
The Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, which celebrates its 20th anniversary this year, has published its latest research report.

In the 298-page book that is primarily written in English, all of the 67 research groups of the MDC and the clinical groups in the Experimental and Clinical Research Center (ECRC) of the MDC and of the Charité – Universitätsmedizin Berlin give an overview of their work in 2010 – 2011. Research activities at the MDC focus on cardiovascular and metabolic diseases, cancer, diseases of the nervous system and systems biology.

The presentation of the research groups, technology platforms and technology transfer projects provides insight into the research activities of the MDC. “In recent years the scientists of the MDC have again achieved internationally acclaimed results and published them in leading journals,” said Professor Walter Rosenthal, scientific director of the MDC, in his introduction to the research report. In 2010 the MDC ranked 14th on the Thomson Reuters list in the field of molecular biology and genetics, making it the only German research institution to be among the world’s “Top Twenty”.

Furthermore, Professor Rosenthal emphasized the MDC’s extensive participation in excellence clusters and collaborative research centers, the acquisition of eight ERC grants and the award of the Leibniz Prize –the most highly endowed German research prize – to Professor Nikolaus Rajewsky, head of the Berlin Institute for Medical Systems Biology (BIMSB) at the MDC, during the period covered by the report.

“The founding charter of the MDC, which was formulated in 1992, is more relevant than ever,” Professor Rosenthal went on to say. “Its aim is to make laboratory results quickly available to doctors and patients in the hospital – as we say the ʽbench to bedsideʼ approach.” In 2007 the Experimental and Clinical Research Center (ECRC), modeled after Clinical Research Centers (CRC) in the U.S., was founded on Campus Berlin-Buch.

As a joint institution of the MDC and the Charité, the ECRC promotes cooperation between basic scientists and clinical researchers in order to accelerate the transfer of insights gained from laboratory research into medical practice. In the future, according to Prof. Rosenthal, the MDC will take its longstanding and close partnership with the Charité to a new level by developing a common institutional platform. This will ensure that “basic biomedical research and clinical research will benefit even more from each other than in the past.”

The MDC was founded on the Campus Berlin-Buch in 1992. It is a member of the Helmholtz Association of German Research Centres and receives its basic operational funding of approximately 71 million euros a year in a fixed ratio of 90 percent from the Federal Ministry of Education and Research and 10 percent from the state of Berlin. In addition, extramural grants acquired by the researchers are in the two-digit million-euro range each year. At present, approximately 1350 people work at the MDC. These include around 1100 research staff members, of whom around 700 are scientists from Germany and from other countries. Along with its partnership with the Charité, the MDC cooperates closely with the Berlin universities, with the Leibniz-Institut für Molekulare Pharmakologie (FMP), the biotechnology park on Campus Berlin-Buch with its 55 companies and with universities and research institutions inside and outside of Germany.

To receive this new research report, please request a copy from the MDC Press Department.

Contact:
Barbara Bachtler
Press Department
Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch
in the Helmholtz Association
Robert-Rössle-Straße 10
13125 Berlin
Germany
Phone: +49 (0) 30 94 06 - 38 96
Fax: +49 (0) 30 94 06 - 38 33
e-mail: presse@mdc-berlin.de

Barbara Bachtler | Max-Delbrück-Centrum
Further information:
http://www.mdc-berlin.de/
http://www.mdc-berlin.de/en/research/research_report/index.html

More articles from Life Sciences:

nachricht Microscope measures muscle weakness
16.11.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

nachricht Good preparation is half the digestion
16.11.2018 | Max-Planck-Institut für Stoffwechselforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>